Details of the Drug Inactive Ingredient (DIG)
General Information of DIG (ID: E09IPB) | |||||
---|---|---|---|---|---|
DIG Name |
Polyethylene glycol 3350
|
||||
DIG Function |
Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
|
||||
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
Minocycline
|
API Info |
Streptococcus bacterial infection [ICD-11: 1C41]
|
[1] | |||
Metronidazole
|
API Info |
Amebiasis [ICD-11: 1A36]
|
[2] | |||
Ribavirin
|
API Info |
Viral hepatitis [ICD-11: 1E51]
|
[3] | |||
Griseofulvin
|
API Info |
Dermatophytosis [ICD-11: 1F28]
|
[4] | |||
Raltegravir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[5] | |||
Chloroquine
|
API Info |
Malaria [ICD-11: 1F40]
|
[6] | |||
Entecavir
|
API Info |
Viral hepatitis [ICD-11: 1E51]
|
[7] | |||
Ritonavir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[8] | |||
Darunavir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[9] | |||
Zidovudine
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[10] | |||
Hydroxychloroquine
|
API Info |
Malaria [ICD-11: 1F40]
|
[11] | |||
Elvitegravir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[12] | |||
Cobicistat
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[13] | |||
Telaprevir
|
API Info |
Viral hepatitis [ICD-11: 1E51]
|
[14] | |||
Posaconazole
|
API Info |
Candidiasis [ICD-11: 1F23]
|
[15] | |||
Tenofovir alafenamide
|
API Info |
Viral hepatitis [ICD-11: 1E51]
|
[16] | |||
Voriconazole
|
API Info |
Candidiasis [ICD-11: 1F23]
|
[17] | |||
ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
Letrozole
|
API Info |
Breast cancer [ICD-11: 2C60]
|
[18] | |||
Abiraterone
|
API Info |
Prostate cancer [ICD-11: 2C82]
|
[19] | |||
Osimertinib
|
API Info |
Lung cancer [ICD-11: 2C25]
|
[20] | |||
Bosutinib
|
API Info |
Chronic myelogenous leukaemia [ICD-11: 2A20]
|
[21] | |||
Cobimetinib
|
API Info |
Melanoma [ICD-11: 2C30]
|
[22] | |||
Mitotane
|
API Info |
Adrenocortical carcinoma [ICD-11: 2D11]
|
[23] | |||
Regorafenib
|
API Info |
Colon cancer [ICD-11: 2B90]
|
[24] | |||
Vemurafenib
|
API Info |
Melanoma [ICD-11: 2C30]
|
[25] | |||
ICD Disease Classification 03 | Blood/blood-forming organ disease | Click to Show/Hide | ||||
Deferiprone
|
API Info |
Thalassaemia [ICD-11: 3A50]
|
[26] | |||
ICD Disease Classification 04 | Immune system disease | Click to Show/Hide | ||||
Cetirizine
|
API Info |
Allergy [ICD-11: 4A80]
|
[27] | |||
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Fenofibrate
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[28] | |||
Simvastatin
|
API Info |
Dyslipidaemia [ICD-11: 5C81]
|
[29] | |||
Glipizide
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[30] | |||
Rosuvastatin
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[31] | |||
Metformin
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[32] | |||
Benzphetamine
|
API Info |
Obesity [ICD-11: 5B81]
|
[33] | |||
Fluvastatin
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[34] | |||
Gemfibrozil
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[35] | |||
Rosiglitazone
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[36] | |||
Canagliflozin
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[37] | |||
Ertugliflozin
|
API Info |
Diabetes mellitus [ICD-11: 5A10]
|
[38] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Risperidone
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[39] | |||
Bupropion
|
API Info |
Nicotine dependence [ICD-11: 6C4A]
|
[40] | |||
Fluoxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[41] | |||
Duloxetine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[42] | |||
Venlafaxine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[43] | |||
Sertraline
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[44] | |||
Hydroxyzine
|
API Info |
Anxiety disorder [ICD-11: 6B00]
|
[45] | |||
Methylphenidate
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[46] | |||
Trazodone
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[47] | |||
Tranylcypromine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[48] | |||
Protriptyline
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[49] | |||
Phenelzine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[50] | |||
ICD Disease Classification 07 | Sleep-wake disorder | Click to Show/Hide | ||||
Eszopiclone
|
API Info |
Insomnia [ICD-11: 7A00]
|
[51] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Morphine
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[52] | |||
Gabapentin
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[53] | |||
Valproic acid
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[54] | |||
Levetiracetam
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[55] | |||
Tramadol
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[56] | |||
Topiramate
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[57] | |||
Hydromorphone
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[58] | |||
Hydrocodone
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[59] | |||
Donepezil
|
API Info |
Alzheimer disease [ICD-11: 8A20]
|
[60] | |||
Sumatriptan
|
API Info |
Migraine [ICD-11: 8A80]
|
[61] | |||
Naratriptan
|
API Info |
Migraine [ICD-11: 8A80]
|
[62] | |||
Pimavanserin
|
API Info |
Parkinsonism [ICD-11: 8A00]
|
[63] | |||
Brivaracetam
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[64] | |||
ICD Disease Classification 10 | Ear/mastoid process disease | Click to Show/Hide | ||||
Amoxicillin
|
API Info |
Acute otitis media [ICD-11: AB00]
|
[65] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Metoprolol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[66] | |||
Losartan
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[67] | |||
Nifedipine
|
API Info |
Angina pectoris [ICD-11: BA40]
|
[68] | |||
Clopidogrel
|
API Info |
Deep vein thrombosis [ICD-11: BD71]
|
[69] | |||
Valsartan
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[70] | |||
Spironolactone
|
API Info |
Congestive heart failure [ICD-11: BD10]
|
[71] | |||
Labetalol
|
API Info |
Essential hypertension [ICD-11: BA00]
|
[72] | |||
Nitroglycerin
|
API Info |
Acute coronary syndrome [ICD-11: BA4Z]
|
[73] | |||
Rivaroxaban
|
API Info |
Deep vein thrombosis [ICD-11: BD71]
|
[74] | |||
Ambrisentan
|
API Info |
Pulmonary hypertension [ICD-11: BB01]
|
[75] | |||
Ranolazine
|
API Info |
Angina pectoris [ICD-11: BA40]
|
[76] | |||
ICD Disease Classification 12 | Respiratory system disease | Click to Show/Hide | ||||
Montelukast
|
API Info |
Asthma [ICD-11: CA23]
|
[77] | |||
Clarithromycin
|
API Info |
Pneumocystis pneumonia [ICD-11: CA40]
|
[78] | |||
Ivacaftor
|
API Info |
Cystic fibrosis [ICD-11: CA25]
|
[79] | |||
Pirfenidone
|
API Info |
Idiopathic pulmonary fibrosis [ICD-11: CB03]
|
[80] | |||
ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
Doxycycline
|
API Info |
Periodontal disease [ICD-11: DA0C]
|
[81] | |||
Omeprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[82] | |||
Mycophenolate mofetil
|
API Info |
Crohn disease [ICD-11: DD70]
|
[83] | |||
Ursodeoxycholic acid
|
API Info |
Hepatic fibrosis/cirrhosis [ICD-11: DB93]
|
[84] | |||
Famotidine
|
API Info |
Peptic ulcer [ICD-11: DA61]
|
[85] | |||
Alvimopan
|
API Info |
Gastrointestinal disease [ICD-11: DE2Z]
|
[86] | |||
Obeticholic acid
|
API Info |
Cholangitis [ICD-11: DC13]
|
[87] | |||
ICD Disease Classification 14 | Skin disease | Click to Show/Hide | ||||
Pseudoephedrine
|
API Info |
Erythema multiforme [ICD-11: EB12]
|
[88] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Naproxen
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[89] | |||
Risedronic acid
|
API Info |
Paget's disease [ICD-11: FB85]
|
[90] | |||
Leflunomide
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[91] | |||
Tofacitinib
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[92] | |||
ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
Ibuprofen
|
API Info |
Dysmenorrhea [ICD-11: GA34]
|
[93] | |||
Oxybutynin
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[94] | |||
Sevelamer
|
API Info |
Chronic kidney disease [ICD-11: GB61]
|
[95] | |||
Trospium
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[96] | |||
ICD Disease Classification 17 | Sexual health-related condition | Click to Show/Hide | ||||
Sildenafil
|
API Info |
Erectile dysfunction [ICD-11: HA01]
|
[97] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
Oxidoreductase (ORase) | ||||||
DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Protein expression upregulation (tested by experiment) | [98] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP3A4_HUMAN | |||||
Primary active transporter (PAT) | ||||||
DBT Name: Multidrug resistance protein 1 (ABCB1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Protein expression downregulation (tested by experiment) | [98] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | MDR1_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.